Wockhardt Q1 FY27 results: Board meet on Aug 10, 2026

Key update: board meeting fixed for August 10

Wockhardt Ltd has scheduled a meeting of its Board of Directors for Monday, August 10, 2026, to consider and approve its quarterly financial results. The agenda, as disclosed to stock exchanges, includes approval of the unaudited financial results for the quarter ended June 30, 2026. The company stated that both standalone and consolidated numbers will be placed before the board.

The disclosure was made under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted to BSE Limited and the National Stock Exchange of India Limited.

Upcoming earnings date and what it covers

The upcoming earnings date for Wockhardt is August 10, 2026, mapped to Q1 FY 2026-27 (quarter ended June 2026). The company’s previous earnings date, as referenced in the data provided, was May 4, 2026 for Q4 FY 2025-26.

A separate note in the dataset also indicates there is “No Quarterly Earnings Forecast data for the stock.” That means consensus estimates and “surprise” tracking are not available in the provided results layer for this quarter.

Trading window: closure timeline

Wockhardt also confirmed that its trading window for dealing in the company’s shares has been closed from Wednesday, July 1, 2026. As per the filing, the trading window will remain closed until 48 hours after the declaration of financial results on August 10, 2026.

This kind of trading-window restriction typically coincides with the period when unpublished price sensitive information may be available internally, and is commonly used to align with insider trading compliance processes.

What the company told exchanges

In its intimation to the exchanges, Wockhardt said the board meeting is being held “inter-alia, to consider and approve” the unaudited financial results for the quarter ended June 30, 2026. The document is signed by Rashmi Mamtura, Company Secretary of Wockhardt Limited. The filing carries the internal reference number WOCK/SEC/SE/2026-27/027.

The disclosure does not provide the Q1 FY27 numbers yet. It is an advance notice of the board meeting where the results are expected to be considered and approved.

Snapshot of recent reported performance (Q4 FY26)

Based on the results information included in the dataset, Wockhardt’s consolidated revenue from operations in Q4 FY26 stood at Rs 965 crore. The same dataset compares this with Rs 888 crore in Q3 FY26 and Rs 743 crore in Q4 FY25. A separate summary panel also lists “Revenue 965” with QoQ growth of 8.67% and YoY growth of 29.88%.

The dataset also highlights profitability indicators for Q4 FY26. It lists gross profit at Rs 172 crore with QoQ growth of 53.57% and YoY growth of 1,463.64%. Net profit is shown at Rs 164 crore in one summary, while a quarterly table lists net income at Rs 166 crore for the quarter ended March 2026.

EBITDA and margin indicators cited in the data

The information provided includes multiple profitability markers for the latest audited period. A press-release-based note states Q4 FY26 EBITDA was Rs 196 crore versus Rs 79 crore in Q4 FY25, with EBITDA margin at 20.3% versus 10.7% a year earlier.

Separately, a “Quick Details” panel in the dataset mentions a previous quarter EBITDA margin of 18.6%. The same panel also lists previous quarter revenue of Rs 3,373 crore and previous quarter PAT of Rs 199 crore.

Context from the audited FY26 filing

Wockhardt filed its Q4 and FY2026 audited standalone and consolidated results with NSE on May 4, 2026. The dataset says the statutory auditor issued an unmodified opinion on the audited FY2026 standalone and consolidated financial results.

For the full year, consolidated FY2026 revenue from operations is reported at Rs 3,373 crore versus Rs 3,012 crore in FY2025, as per the audited-results filing cited in the dataset. FY2026 EBITDA is listed at Rs 630 crore versus Rs 418 crore in FY2025.

Business mix reference: India branded business

The dataset also provides a data point for the India Branded Business. It reports revenue of Rs 112 crore in Q4 FY2026, up 18% year-on-year, and Rs 523 crore for FY2026, up 15% year-on-year.

These figures are presented as part of the broader results commentary, alongside consolidated revenue and profitability metrics.

Market snapshot and positioning cues

The data provided includes several market reference points around the stock. It lists CMP around Rs 2,015.85 and separately shows a price of Rs 2,021, along with P/E of 114.8. Market capitalisation is shown as about Rs 32,735.75 crore (also displayed as approximately Rs 32.6K crore in another panel). The sector is listed as Pharmaceuticals & Biotechnology.

The dataset also notes that Wockhardt enters Q1 FY27 after a “historic U.S. FDA approval” for its novel antibiotic Zaynich, and references a pivot toward high-margin innovation and biosimilars. The filing itself, however, is focused on the board meeting and does not include operational commentary.

Key facts at a glance

Market impact and what to track on August 10

For investors, the August 10 event is primarily a scheduled disclosure catalyst: the board is expected to consider and approve unaudited standalone and consolidated results for the June 2026 quarter. With no quarterly forecast data provided, the focus tends to shift to reported revenue, margins, and profit trajectory compared with recent quarters.

The dataset already provides a reference base for comparison, including Q4 FY26 consolidated revenue of Rs 965 crore and FY26 revenue from operations of Rs 3,373 crore. The trading window closure timeline is also explicit, which matters for compliance-related trading restrictions until 48 hours after the results are declared.

Conclusion

Wockhardt’s Q1 FY27 results are scheduled to be considered at a board meeting on August 10, 2026, as per its exchange filing under SEBI’s listing regulations. The company has also kept the trading window closed from July 1, 2026 until 48 hours after the results are declared. The next concrete update is expected on August 10, when the unaudited standalone and consolidated numbers for the June 2026 quarter are taken up by the board.